GenMark Diagnostics director just picked up 2,432 shares

James Fox, a director of GenMark Diagnostics, recently acquired 2,432 shares of the company. The buys took place at $0.00 per share (and therefore, likely the result of option or restricted share grants), on August 07, 2014. Fox now owns 136,017 shares of the company. Fox operates out of Carlsbad, CA. Some additional info was provided as follows:

The amount reported reflects restricted stock units granted to the reporting person pursuant to the Issuer's 2010 Equity Incentive Plan, which vest in full on May 29, 2015. Dr. Fox is an executive director of Penashe Holdings Propriety Limited and may be deemed to have beneficial ownership of these securities, to the extent of any indirect pecuniary interest in his distributive shares therein.

The above information was disclosed in a filing to the SEC. To see this filing in its entirety, click here. GenMark Diagnostics next reports earnings on August 11, 2014.

To receive a free e-mail notification whenever GenMark Diagnostics makes a similar move, sign up!

Other recent filings from the company include the following:

Statement of acquisition of beneficial ownership by individuals - Jan. 30, 2015
GenMark Diagnostics's President and CEO just picked up 4,818 shares - Jan. 26, 2015
GenMark Diagnostics just filed a General Statement of acquisition of beneficial ownership - Jan. 14, 2015
Current report, items 1.01, 2.02, 2.03, and 9.01 - Jan. 12, 2015
GenMark Diagnostics's President and CEO just disposed of 4,858 shares - Jan. 9, 2015

   Auto Refresh